Gilder Gagnon Howe & CO LLC Adaptive Biotechnologies Corp Transaction History

Gilder Gagnon Howe & CO LLC

$7.87 Billion
Q3 2024

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$2.88 - $4.8 $33,399 - $55,665	11,597 Added 0.94%	1,245,111 $4 Million
Q4 2023 Feb 14, 2024	BUY	$3.46 - $5.33 $32,510 - $50,080	9,396 Added 0.77%	1,233,514 $6.04 Million
Q3 2023 Nov 14, 2023	BUY	$5.07 - $8.44 $43,566 - $72,524	8,593 Added 0.71%	1,224,118 $6.67 Million
Q2 2023 Aug 14, 2023	BUY	$6.19 - $8.78 $284,770 - $403,923	46,005 Added 3.93%	1,215,525 $8.16 Million
Q1 2023 May 15, 2023	BUY	$7.8 - $10.11 $9.12 Million - $11.8 Million	1,169,520 New	1,169,520 $10.3 Million
Q1 2022 May 16, 2022	SELL	$10.12 - $28.9 $9.54 Million - $27.2 Million	-942,666 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$25.17 - $36.85 $25.9 Million - $37.8 Million	-1,027,060 Reduced 52.14%	942,666 $26.5 Million
Q3 2021 Nov 15, 2021	SELL	$30.02 - $39.87 $2.41 Million - $3.2 Million	-80,237 Reduced 3.91%	1,969,726 $67 Million
Q2 2021 Aug 16, 2021	SELL	$32.22 - $44.59 $10.8 Million - $14.9 Million	-334,242 Reduced 14.02%	2,049,963 $83.8 Million
Q1 2021 May 17, 2021	BUY	$37.26 - $67.74 $350,504 - $637,230	9,407 Added 0.4%	2,384,205 $96 Million
Q4 2020 Feb 16, 2021	SELL	$45.01 - $65.47 $1.01 Million - $1.47 Million	-22,481 Reduced 0.94%	2,374,798 $140 Million
Q3 2020 Nov 16, 2020	SELL	$35.79 - $48.81 $2.08 Million - $2.83 Million	-57,990 Reduced 2.36%	2,397,279 $117 Million
Q2 2020 Aug 14, 2020	BUY	$24.95 - $48.38 $4.39 Million - $8.52 Million	176,019 Added 7.72%	2,455,269 $119 Million
Q1 2020 May 15, 2020	BUY	$16.96 - $34.16 $25.3 Million - $51 Million	1,494,052 Added 190.28%	2,279,250 $63.3 Million
Q4 2019 Feb 14, 2020	SELL	$24.56 - $32.8 $182,308 - $243,474	-7,423 Reduced 0.94%	785,198 $23.5 Million
Q3 2019 Nov 14, 2019	BUY	$30.31 - $53.51 $6.09 Million - $10.7 Million	200,872 Added 33.95%	792,621 $24.5 Million
Q2 2019 Aug 13, 2019	BUY	$40.3 - $48.3 $23.8 Million - $28.6 Million	591,749 New	591,749 $28.6 Million

Others Institutions Holding ADPT

# of Institutions

202

Shares Held

146M

Call Options Held

68.8K

Put Options Held

42.5K

Viking Global Investors LP

30M
Shares

$192 Million
0.59% of portfolio
Rubric Capital Management LP New York, NY

14.4M
Shares

$92 Million
2.05% of portfolio
Black Rock Inc. New York, NY

11.7M
Shares

$74.5 Million
0.0% of portfolio
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl

11.6M
Shares

$74.1 Million
0.56% of portfolio
Vanguard Group Inc Valley Forge, PA

10.6M
Shares

$68 Million
0.0% of portfolio

View Full List

About Adaptive Biotechnologies Corp

Ticker ADPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 142,872,992
Market Cap $913M
Description
Adaptive Biotechnologies Corporation, a commercial-stage company, develops an immune medicine platform for the diagnosis and treatment of various diseases. The company offers immunoSEQ, a platform and core immunosequencing product that is used to answer translational research questions, as well as to discover new prognostic and diagnostic signal...

More about ADPT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Gilder Gagnon Howe & CO LLC, based on Form 13F filings with the SEC.

News

Stay updated on Gilder Gagnon Howe & CO LLC with notifications on news.

Account